Guardian Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.13M | Sell |
12,425
-1,750
| -12% | -$377K | 2.02% | 15 |
|
|
2026
Q1 | $3.08M | Buy |
14,175
+30
| +0.2% | +$6.66K | 2.43% | 13 |
|
|
2025
Q4 | $3.23M | Sell |
14,145
-100
| -0.7% | -$22.8K | 2.52% | 12 |
|
|
2025
Q3 | $3.3M | Sell |
14,245
-50
| -0.3% | -$10.2K | 2.8% | 9 |
|
|
2025
Q2 | $2.65M | Sell |
14,295
-2,105
| -13% | -$391K | 2.67% | 9 |
|
|
2025
Q1 | $3.44M | Sell |
16,400
-1,401
| -8% | -$272K | 2.89% | 8 |
|
|
2024
Q4 | $3.16M | Sell |
17,801
-450
| -2% | -$82.7K | 2.26% | 10 |
|
|
2024
Q3 | $3.6M | Sell |
18,251
-1,475
| -7% | -$275K | 3.1% | 8 |
|
|
2024
Q2 | $3.38M | Sell |
19,726
-500
| -2% | -$82.8K | 2.42% | 12 |
|
|
2024
Q1 | $3.68M | Sell |
20,226
-1,895
| -9% | -$327K | 2.96% | 10 |
|
|
2023
Q4 | $3.43M | Sell |
22,121
-700
| -3% | -$102K | 2.89% | 9 |
|
|
2023
Q3 | $3.4M | Buy |
22,821
+27
| +0.1% | +$3.96K | 3.09% | 9 |
|
|
2023
Q2 | $3.07M | Sell |
22,794
-6,723
| -23% | -$986K | 2.61% | 10 |
|
|
2023
Q1 | $3.19M | Buy |
29,517
+5,700
| +24% | +$871K | 2.39% | 11 |
|
|
2022
Q4 | $3.85M | Hold |
23,817
| – | – | 3.64% | 6 |
|
|
2022
Q3 | $3.2M | Sell |
23,817
-3,200
| -12% | -$459K | 3.24% | 5 |
|
|
2022
Q2 | $4.14M | Hold |
27,017
| – | – | 3.6% | 4 |
|
|
2022
Q1 | $4.38M | Buy |
27,017
+600
| +2% | +$87.2K | 3.4% | 5 |
|
|
2021
Q4 | $3.58M | Hold |
26,417
| – | – | 2.49% | 10 |
|
|
2021
Q3 | $2.85M | Sell |
26,417
-2,900
| -10% | -$331K | 2.1% | 18 |
|
|
2021
Q2 | $3.3M | Sell |
29,317
-200
| -0.7% | -$22.5K | 2.26% | 16 |
|
|
2021
Q1 | $3.19M | Hold |
29,517
| – | – | 2.27% | 14 |
|
|
2020
Q4 | $3.16M | Hold |
29,517
| – | – | 2.4% | 11 |
|
|
2020
Q3 | $2.58M | Hold |
29,517
| – | – | 2.25% | 18 |
|
|
2020
Q2 | $2.9M | Sell |
29,517
-1,299
| -4% | -$114K | 2.63% | 10 |
|
|
2020
Q1 | $2.35M | Sell |
30,816
-200
| -0.6% | -$17K | 2.4% | 14 |
|
|
2019
Q4 | $2.75M | Hold |
31,016
| – | – | 2.18% | 17 |
|
|
2019
Q3 | $2.35M | Sell |
31,016
-100
| -0.3% | -$6.86K | 2.09% | 15 |
|
|
2019
Q2 | $2.26M | Hold |
31,116
| – | – | 1.97% | 18 |
|
|
2019
Q1 | $2.51M | Sell |
31,116
-33
| -0.1% | -$2.7K | 2.17% | 18 |
|
|
2018
Q4 | $2.87M | Buy |
31,149
+1,033
| +3% | +$90.8K | 2.65% | 13 |
|
|
2018
Q3 | $2.85M | Buy |
30,116
+200
| +0.7% | +$19K | 2.51% | 15 |
|
|
2018
Q2 | $2.77M | Buy |
29,916
+500
| +2% | +$48.8K | 2.65% | 13 |
|
|
2018
Q1 | $2.78M | Sell |
29,416
-500
| -2% | -$54.9K | 2.97% | 12 |
|
|
2017
Q4 | $2.89M | Sell |
29,916
-1,500
| -5% | -$141K | 3.05% | 12 |
|
|
2017
Q3 | $2.79M | Hold |
31,416
| – | – | 3.08% | 13 |
|
|
2017
Q2 | $2.28M | Sell |
31,416
-1,300
| -4% | -$87.4K | 2.52% | 14 |
|
|
2017
Q1 | $2.13M | Buy |
32,716
+8,600
| +36% | +$541K | 2.32% | 16 |
|
|
2016
Q4 | $1.51M | Buy |
24,116
+1,700
| +8% | +$104K | 1.74% | 21 |
|
|
2016
Q3 | $1.39M | Hold |
22,416
| – | – | 1.54% | 25 |
|
|
2016
Q2 | $1.39M | Buy |
22,416
+200
| +0.9% | +$12.2K | 1.54% | 25 |
|
|
2016
Q1 | $1.27M | Sell |
22,216
-2,000
| -8% | -$111K | 1.45% | 27 |
|
|
2015
Q4 | $1.44M | Buy |
24,216
+700
| +3% | +$40.3K | 1.54% | 26 |
|
|
2015
Q3 | $1.3M | Sell |
23,516
-1,484
| -6% | -$96.6K | 1.44% | 27 |
|
|
2015
Q2 | $1.71M | Buy |
25,000
+5,000
| +25% | +$326K | 1.91% | 20 |
|
|
2015
Q1 | $1.16M | Hold |
20,000
| – | – | 1.29% | 33 |
|
|
2014
Q4 | $1.64M | Hold |
20,000
| – | – | 1.72% | 21 |
|
|
2014
Q3 | $1.03M | Hold |
20,000
| – | – | 1.19% | 38 |
|
|
2014
Q2 | $1.13M | Hold |
20,000
| – | – | 1.23% | 37 |
|
|
2014
Q1 | $1.03M | Hold |
20,000
| – | – | 1.19% | 38 |
|
|
2013
Q4 | $1.06M | Hold |
20,000
| – | – | 1.18% | 38 |
|
|
2013
Q3 | $900K | Hold |
20,000
| – | – | 1.22% | 38 |
|
|
2013
Q2 | $831K | Buy |
+20,000
| New | +$875K | 1.2% | 38 |
|
Other funds holding ABBV
ATO
Guardian Investment Management's ABBV Position: Q2 2026 in Review
Guardian Investment Management reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $377K and leaving 12,425 shares worth $3.13M. The position accounts for 2.02% of the portfolio, ranked #15.
Guardian Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.38M in Q1 2022. 1,757 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Guardian Investment Management held 12,425 shares of AbbVie worth $3.13M as of Q2 2026.
- Guardian Investment Management sold 1,750 AbbVie shares in Q2 2026, an estimated $377K.
- AbbVie made up 2.02% of Guardian Investment Management's portfolio in Q2 2026, its #15 holding.
- Guardian Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Guardian Investment Management's AbbVie position peaked at $4.38M in Q1 2022.
- 1,757 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.